TERESA COOPER: Open Payments
NPI 1730675059 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 44 payments from 12 companies in 2025. Trend: 2023 $81 · 2024 $131 · 2025 $765
Food & beverage: $765
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $185 |
| Eisai Inc. | 6 | $172 |
| ABBVIE INC. | 15 | $170 |
| UCB, Inc. | 2 | $47 |
| InspireMD Ltd | 1 | $42 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Biogen, Inc. | 1 | $23 |
| ARGENX US, INC. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
Products named: Leqembi, NURTEC ODT, UBRELVY, QULIPTA, Briviact, CGuard Prime Carotid Stent System, WAINUA, VYALEV.
Industry payments across AL — which companies pay providers there.
